Male sex |
14 (58) |
CHAD2S2VASc score |
2
(1–3) |
Hypertension |
13 (54) |
Diabetes |
2 (8) |
Stroke or TIA history |
1 (5) |
Structural heart disease |
8 (33) |
Ischemic
|
2 (8)
|
Valvular
|
6 (25)
|
LA sizea, cm2
|
28.4 ±
4.6 |
LVEFb, % |
62 (55–75) |
No. of previously failed lines of AAR drugs |
2 (1–2) |
Previously failed AAR drugs |
|
Amiodarone
|
23 (96)
|
Flecainide
|
5 (21)
|
Propafenone
|
1 (5)
|
Sotalol
|
1 (5)
|
None
|
1 (5)
|
Time since first sustained atrial arrhythmia, months |
60
(22–108) |
Time since persistent AF installation, months |
7 (4–11) |
Previous ablations |
12 (50) |
Previous CTI ablation
|
12 (50)
|
Previous AF ablation
|
10 (42)
|
≥ 2 previous AF ablations
|
4 (21)
|
Previous PVI
|
10 (42)
|
Previous roof line
|
7 (29)
|
Previous CFAE ablation
|
3 (13)
|
Previous mitral isthmus line
|
0 (0)
|
Previous anterior mitral line
|
1 (5)
|